INNT
TOTAL INVALIDATION PROCESSED BY THE IB
07/16/2026
Back to search
Official data from USPTO
BIOCELLIC+
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
45
Latest update
07/16/2026
Trademark type
Combined
Nice classes
1, 3, 5
Filing date
01/28/2016
Registration date
09/11/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/28/2025
Last transaction
07/16/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
3
Owner type
16
Owner location
DE
Examiner
BLANE, SUZANNE
Law office
M50
Current location
TMO LAW OFFICE 114
Holders and representatives
Holders
JeNaCell GmbH
JeNaCell GmbH
Representatives
Fuchs Patentanwälte Partnerschaft mbB
Technical classification
Nice Classes
Class 1Class 3Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Cellulose precursors and cellulose intermediates for cosmeticpharmaceuticalmedical and veterinary-medical end products; cellulose products for use in the manufacture of wound dressings; cellulose made by bacteria; cellulose for industrial purposes; cellulose gel for use in manufacturing; nanocellulose for use in manufacturing; unprocessed cellulose fleececellulose foilcellulose films and cellulose fibresall for use in manufacturing goods in the cosmetic and medical industries; cellulose fibres suspensions and cellulose gels of nanocellulose; cellulose fibres suspensions and cellulose gels of cellulose and water; unprocessed cellulose fleececellulose foilcellulose films and cellulose fibres for use in food and beverages; cellulose fibres suspensions and cellulose gels for use in food and beverages; Thickening agents being biochemical products for industrial use; cellulose and nanocellulose products as precursors for veterinarycosmetic productsparticularly for wound dressings; cellulose ingredients for use in manufacturing goods in the cosmetic and medical industries; cellulose and nanocellulose products as precursors for pharmaceutical products; cellulose-based ingredients for manufacturing goods in the cosmetics industry and the medical device industry; cellulose-based ingredients as support materialthickening and binding agents for the manufacture of cosmetics and medical productsparticularly wound dressings and skin care preparations; cellulose for the food industry; cellulose derivatives for use in manufacturing; diagnostic preparations and substances for scientific purposes; diagnostic testing materials for scientific use; * none of the above-mentioned goods being products to be taken orally; none of the above-mentioned goods being products containing collagen *
Class 3
Cosmetics and cosmetic preparations; cellulose fleececellulose foilscellulose filmscellulose fibrescellulose fibre suspensions and cellulose gels impregnated with cosmetic active ingredientsparticularly skin care preparations; beauty masks; skin masks; facial masks; body masksunmedicated skin care preparations; * none of the above-mentioned goods being products containing collagen *
Class 5
Pharmaceutical preparations for skin care; pantyliners; sanitary pads; medicated preparations for the treatment of burns with the exception of ready-to-use wound dressings; diagnostic preparations for pharmaceuticalmedical and veterinary purposes; * none of the above-mentioned goods are sticking plasters or plasters for medical use and none of the above-mentioned goods are ready-to-use surgical dressings; insofar as the above-mentioned goods relate to non-pharmaceutical productsthe latter are not provided for oral medication; insofar as the above-mentioned goods relate to pharmaceutical products to be taken orallythe latter are free from collagenchondroitin sulfate and/or hyaluronic acid; none of the above-mentioned goods are nutritional supplements containing collagenchondroitin sulfate and/or hyaluronic acid; none of the above-mentioned goods are products containing collagen *
Publications
History of USPTO decisions and trademark events.
45 publications found
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
06/22/2026
INPC
INVALIDATION PROCESSED
06/22/2026
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
11/28/2025
C71T
CANCELLED SECTION 71
03/28/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/18/2023
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
08/12/2022
INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
10/21/2019
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
10/04/2019
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/15/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
01/24/2019
FIMP
FINAL DISPOSITION PROCESSED
01/24/2019
LIME
LIMITATION FROM THE IB EXAMINED AND ENTERED
01/24/2019
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
01/23/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/07/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/11/2018
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
11/02/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
09/11/2018
PUBO
PUBLISHED FOR OPPOSITION
06/26/2018
GPNX
NOTIFICATION PROCESSED BY IB
06/23/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/06/2018
NPUB
NOTICE OF PUBLICATION
06/06/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
06/06/2018
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
04/10/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/22/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/02/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/01/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/01/2018
CNRT
NON-FINAL ACTION MAILED
11/21/2017
CNRT
NON-FINAL ACTION WRITTEN
11/21/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/30/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/30/2017
ALIE
ASSIGNED TO LIE
10/30/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/18/2017
LIME
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
10/18/2017
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
08/25/2017
RFNT
REFUSAL PROCESSED BY IB
05/05/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/19/2017
RFRR
REFUSAL PROCESSED BY MPU
04/19/2017
MAFR
APPLICATION FILING RECEIPT MAILED
04/18/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/16/2017
CNRT
NON-FINAL ACTION WRITTEN
04/15/2017
DOCK
ASSIGNED TO EXAMINER
04/14/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/14/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/13/2017
Continuous trademark protection
Get notified about every new filing that threatens BIOCELLIC+ or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.